Magnetic resonance imaging is an effective alternative to ultrasounds and CT scans in diagnosing pediatric appendicitis.
Magnetic resonance imaging without contrast is a viable alternative test for suspected pediatric appendicitis, according to a study in the journal Radiology.
Researchers from the Texas Children’s Hospital in Houston performed a study of 81 patients (34 male, 47 female) to prospectively compare MR imaging without contrast and ultrasound for diagnosis of pediatric appendicitis. The mean age was 12.3 years. Traditionally, if ultrasound is inconclusive, ultrasound followed by CT scan is used for diagnosis. However, ultrasounds are not always available and CT scans increase the patients’ overall exposure to radiation.
All patients underwent an ultrasound of the right lower quadrant, as well as a nonenhanced nonsedated abdominopelvic MR imaging exam. Two pediatric radiologists who were blinded to the ultrasound findings reviewed the MR images.
When equivocal interpretations were designated positive, sensitivity was 93.3 percent for MR imaging and 90.0 percent for ultrasound. The specificity was 98 percent for MR imaging and 86.3 percent for ultrasound. Positive predictive value was 96.5 percent for MR imaging and 79.4 percent for ultrasound; and negative predictive value was 96.2 percent for MR imaging and 93.6 percent for ultrasound.
When equivocal interpretations were designated negative, MR imaging sensitivity, specificity, positive predictive value and negative predictive value were unchanged. For ultrasound, sensitivity was 86.7 percent; specificity was 100 percent; positive predictive value was 100 percent; and negative predictive value was 92.7 percent.
The authors concluded that nonenhanced MR imaging demonstrated high diagnostic performance that was similar to that of ultrasound in the pediatric population.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.